ASTENA HOLDINGS CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 486 JPY | 0.00% |
|
-0.21% | +2.10% |
| Sales 2022 | 49.64B 319M | Sales 2023 | 51.98B 334M | Capitalization | 19.63B 126M |
|---|---|---|---|---|---|
| Net income 2022 | 579M 3.72M | Net income 2023 | 1.16B 7.47M | EV / Sales 2022 | 0.49 x |
| Net Debt 2022 | 8.09B 52.05M | Net Debt 2023 | 10.04B 64.58M | EV / Sales 2023 | 0.57 x |
| P/E ratio 2022 |
28.7
x | P/E ratio 2023 |
16.9
x | Employees | 1,404 |
| Yield 2022 |
4.32% | Yield 2023 |
3.62% | Free-Float | 77.4% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.21% | ||
| 1 week | -0.41% | ||
| Current month | -1.42% | ||
| 1 month | +0.83% | ||
| 3 months | +0.41% | ||
| 6 months | -9.35% | ||
| Current year | +1.89% |
1 week
473.00
489.00
1 month
473.00503.00
Current year
461.00503.00
1 year
424.00548.00
3 years
366.00781.00
5 years
352.00783.00
10 years
173.00783.00
| Managers | Title | Age | Since |
|---|---|---|---|
Keitaro Iwaki
CEO | Chief Executive Officer | 46 | 05-03-31 |
Isamu Ueyama
DFI | Director of Finance/CFO | - | - |
Minoru Kadokura
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Osamu Iwaki
CHM | Chairman | 73 | 73-03-31 |
Keitaro Iwaki
CEO | Chief Executive Officer | 46 | 05-03-31 |
Taizo Ochi
BRD | Director/Board Member | 78 | 15-01-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.05% | 32 M€ | +28.22% | ||
| 0.00% | 144,586 M€ | +14.04% | ||
| 0.00% | 66,066 M€ | +14.04% | - | |
| 0.00% | 20,721 M€ | +12.98% | - | |
| 0.00% | 18 M€ | +16.15% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 486 | 0.00% | 51 200 |
| 24-04-24 | 486 | -0.41% | 56,700 |
| 24-04-23 | 488 | +0.41% | 55,200 |
| 24-04-22 | 486 | +1.46% | 52,500 |
| 24-04-19 | 479 | -1.64% | 115,400 |
Delayed Quote Japan Exchange, April 24, 2024 at 11:33 pm EDT
More quotes
Astena Holdings Co Ltd, formerly Iwaki & Co Ltd is a Japan-based company primarily engaged in the fine chemicals business, medical business, health & beauty care (HBC) and food business, and industrial chemicals business. The Company operates through four business segments. The Fine Chemicals segment is engaged in manufacture and sale of pharmaceutical raw materials and pharmaceuticals. The Medical segment is engaged in the manufacturing and sales of pharmaceutical products. The HBC and Food segment is engaged in the manufacture and sale of cosmetic raw materials, functional food raw materials, general use medicines and related products, as well as cosmetics. The Industrial Chemicals segment manufactures and sells chemicals for electronic industries, surface treatment chemicals, chemical products, surface treatment chemical raw materials, as well as to printed circuit board and other manufacturing plants. The other businesses include consulting services and others.
Sector
Pharmaceuticals
Calendar
| 1st Jan change | Capi. | |
|---|---|---|
| +1.89% | 125M | |
| +25.61% | 672B | |
| +25.87% | 570B | |
| -5.24% | 360B | |
| +16.49% | 321B | |
| +8.28% | 300B | |
| +7.09% | 217B | |
| -9.12% | 204B | |
| +5.01% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- 8095 Stock
